4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-23-010819
CEO sold 11,654 shares at an average $29.63 ($345,334)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2023-04-03 | Sale 10b5-1 | −5,161 | $30.31 | $156,430 | 1,124,472 | D |
| Evans John M. CEO | 2023-04-04 | Sale 10b5-1 | −6,493 | $29.09 | $188,904 | 1,117,979 | D |
| Open-market sales · 11,654 sh · avg $29.63 · $345,334 | |||||||
Loading xslF345X04/doc4.xml…